Biocryst Pharmaceuticals (BCRX) Net Margin Growth (5y) (2015 - 2026)
Biocryst Pharmaceuticals (BCRX) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,239.00 |
| Mar 31, 2026 | -12,419.00 |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 76,363.00 |
| Jun 30, 2025 | 135,003.00 |
| Mar 31, 2025 | 77,918.00 |
| Dec 31, 2024 | -1,227.00 |
| Sep 30, 2024 | 211,421.00 |
| Jun 30, 2024 | 257,170.00 |
| Mar 31, 2024 | 49,626.00 |
| Dec 31, 2023 | 85,941.00 |
| Sep 30, 2023 | 203,728.00 |
| Jun 30, 2023 | 7,214.00 |
| Mar 31, 2023 | 54,288.00 |
| Dec 31, 2022 | 41,428.00 |
| Sep 30, 2022 | 11,817.00 |
| Jun 30, 2022 | 47,882.00 |
| Mar 31, 2022 | -1,324.00 |
| Dec 31, 2021 | 8,275.00 |
| Sep 30, 2021 | -522.00 |